Cranial vascular effects of zolmitriptan, a centrally active 5-HT 1B/1D receptor partial agonist for the acute treatment of migraine

Author: MacLennan S.J.   Cambridge D.   Whiting M.V.   Marston C.   Martin G.R.  

Publisher: Elsevier

ISSN: 0014-2999

Source: European Journal of Pharmacology, Vol.361, Iss.2, 1998-11, pp. : 191-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract